(SIBD) Swedish Inflammatory Bowel Disease Conference - May 31, 2025 - Westin, Bellevue, WA
Please join us at for our annual Swedish IBD update on Saturday, May 31st, 2025!
*In-Person and Virtual -- We are offering this meeting as a Hybrid Webinar -- Just register and select in-person or virtual attendance. Remote connection information will be provided 3 days prior to the meeting. Recordings and CME will be made available for 90 days for all participants.
The annual Swedish Providence Update in Inflammatory Bowel Disease course will review new and forthcoming medical and surgical therapeutic approaches in IBD and its associated manifestations, as well their impact on the current management of these conditions. The therapeutic landscape in IBD continues to evolve, resulting in rapid and dramatic changes to therapeutic algorithms and disease monitoring. The course will review the impact of positioning new therapeutics, optimization of medical therapy, disease management in the perioperative period, extraintestinal manifestations, dietary, nonpharmacologic therapies and multi-disciplinary approaches to complex clinical scenarios including strictures. It will also cover novel therapies including the advent of small molecules and their impact in the management of IBD patients.
Teaching methods include lecture/didactic, Q&A with faculty, panel discussion, case presentation and audience response system.
This year's keynote speaker is Dr. Remo Panaccione, Professor of Medicine, Director IBD Unit, University of Calgary, Canada. Dr/Prof Remo Panaccione is a Professor of Medicine and the Director of the Inflammatory Bowel Disease Unit at the University of Calgary, Calgary, Canada. He serves as the Dean of MD Admissions and Director of the IBD Fellowship Program. He holds the Crohn’s Colitis Canada Endowed Research Chair in Inflammatory Bowel Disease. He serves as an executive member for the International Organization for the Study of IBD (IOIBD). He is the 2020 Crohn's Colitis Canada Outstanding Physician of the Year and has been recognized as a 2020-23 Clarivate Research Scholar for being cited in the top 1% of researchers in the world. He has co-authored over 350 manuscripts, 20 book chapters, and 625 abstracts including publications in journals such as the New England Journal of Medicine, Lancet, JAMA, Nature, and Annals of Internal Medicine.
Event Links
Website: https://go.evvnt.com/2672697-5
Tickets: https://go.evvnt.com/2672697-2
Exhibitor: https://go.evvnt.com/2672697-6
